AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29427533 — intervention group
Group type: EXPERIMENTAL
Intervention: VeinViewer®
Number of subjects: 40
Study 29427533 — intervention group
Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 40
Study 27371449 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy before training sessions
Number of subjects: 48
Study 27371449 — intervention group
Group type: COMPARATOR
Intervention: Placebo after training sessions
Number of subjects: 48
Study 24552555 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care + brief ACT-based intervention (five group therapy sessions integrating educational topics on heart-healthy behaviours with acceptance and mindfulness skills)
Number of subjects: 168
Study 24552555 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 168
Study 22136711 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g/d of fish oil (1.6 g/d EPA+DHA; n=17)
Number of subjects: 54
Study 22136711 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 g/d of oxidised fish oil (1.6 g/d EPA+DHA; n=18)
Number of subjects: 54
Study 22136711 — intervention group
Group type: COMPARATOR
Intervention: 8 g/d of high-oleic sunflower oil (n=19)
Number of subjects: 54
Study 22136711 — intervention group
Group type: EXPERIMENTAL
Intervention: Both fish oil groups (8 g/d of fish oil and 8 g/d of oxidised fish oil)
Number of subjects: 54
Study 19130965 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscope-assisted partial parotidectomy
Number of subjects: 38
Study 19130965 — intervention group
Group type: COMPARATOR
Intervention: Conventional partial parotidectomy
Number of subjects: 38
Study 18661414 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low molecular weight iron dextran (ID)
Number of subjects: 339
Study 18661414 — intervention group
Group type: COMPARATOR
Intervention: Sodium ferrigluconate complex (SFGC)
Number of subjects: 339
Study 18661414 — intervention group
Group type: COMPARATOR
Intervention: Iron sucrose (IS)
Number of subjects: 339
Study 18661414 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison of ID, SFGC, and IS
Number of subjects: 339
Study 18661414 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug discontinuation
Number of subjects: 339
Study 18661414 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaphylactoid reaction
Number of subjects: 339
Study 16029455 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (MPM)
Number of subjects: 232
Study 16029455 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam (P/T)
Number of subjects: 232
Study 11975426 — intervention group
Group type: EXPERIMENTAL
Intervention: Brotizolam 0.25 mg
Number of subjects: 40
Study 11975426 — intervention group
Group type: COMPARATOR
Intervention: Zopiclone 7.5 mg
Number of subjects: 40
Study 10030617 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast sensitivity measured with sine-wave grating patches at varying luminance and eccentricity levels.
Number of subjects: 18
Study 7722762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual energy x-ray absorptiometry (DXA)
Number of subjects: 69
Study 2185299 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg glypressin intravenously (i.v.)
Number of subjects: 20
Study 2185299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7379678 — intervention group
Group type: EXPERIMENTAL
Intervention: Bile salts (5 mM, pH 5.5, 280 mOsm, 37 degrees C)
Number of subjects: 8
Study 7379678 — intervention group
Group type: COMPARATOR
Intervention: Saline solution without bile salts
Number of subjects: 8
Study 30006846 — intervention group
Group type: EXPERIMENTAL
Intervention: SILS + 1
Number of subjects: 198
Study 30006846 — intervention group
Group type: COMPARATOR
Intervention: CLS
Number of subjects: 198
Study 30006846 — intervention group
Group type: EXPERIMENTAL
Intervention: SILS + 1 and CLS
Number of subjects: 198
Study 30594237 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min of cycle ergometry at 50‐60% of maximum heart rate
Number of subjects: 0
Study 30594237 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min of exercise at 70‐80% of maximum heart rate
Number of subjects: 0
Study 30594237 — intervention group
Group type: COMPARATOR
Intervention: 20 min of quiet reading
Number of subjects: 0
Study 27061165 — intervention group
Group type: EXPERIMENTAL
Intervention: History of substance use disorder (SUD)
Number of subjects: 143
Study 27061165 — intervention group
Group type: COMPARATOR
Intervention: Control (No history of substance use disorder)
Number of subjects: 143
Study 24675910 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (ECCT)
Number of subjects: 105
Study 24675910 — intervention group
Group type: COMPARATOR
Intervention: Concentric control (CONCC)
Number of subjects: 105
Study 24675910 — intervention group
Group type: COMPARATOR
Intervention: Eccentric control (ECCC)
Number of subjects: 105
Study 22089177 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiawei Qing'e Fang (JQF)
Number of subjects: 72
Study 22089177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 20636718 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with uric acid (1 g) and rtPA
Number of subjects: 420
Study 20636718 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone (control)
Number of subjects: 420
Study 17644313 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0
Study 17644313 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study 16645532 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifuga racemosa (CR) 40 mg/day
Number of subjects: 62
Study 16645532 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens (CE) 0.6 mg/day
Number of subjects: 62
Study 16645532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 12507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with the dominant hand
Number of subjects: 25
Study 12507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with the subdominant hand
Number of subjects: 25
Study 12507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with both hands
Number of subjects: 25
Study 12507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual training
Number of subjects: 25
Study 12507049 — intervention group
Group type: EXPERIMENTAL
Intervention: Unimanual training
Number of subjects: 25
Study 10690159 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartame
Number of subjects: 10
Study 10690159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MJ simple carbohydrate
Number of subjects: 10
Study 10690159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MJ high-fat
Number of subjects: 10
Study 10690159 — intervention group
Group type: EXPERIMENTAL
Intervention: All drinks combined
Number of subjects: 10
Study 8579032 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 6797
Study 8579032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6797
Study 1902411 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus glibenclamide (DPG)
Number of subjects: 14
Study 1902411 — intervention group
Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 14
Study 6762167 — intervention group
Group type: EXPERIMENTAL
Intervention: Torasemide 60 mg
Number of subjects: 12
Study 6762167 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 120 mg
Number of subjects: 12
Study 29370424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 220
Study 29370424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 220
Study 29370424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 29370424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg and 10 mg
Number of subjects: 220
Study 27261171 — intervention group
Group type: EXPERIMENTAL
Intervention: Manville Moves exercise intervention using virtual-reality exergaming bicycles (cybercycles) integrated into physical education classes.
Number of subjects: 0
Study 25559494 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 15
Study 25559494 — intervention group
Group type: COMPARATOR
Intervention: Water consumption
Number of subjects: 15
Study 23384091 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine oral solution (1 mg/ml)
Number of subjects: 360
Study 23384091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 20939473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) 5000 U/day (high dose group)
Number of subjects: 90
Study 20939473 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) 2500 U/day (low dose group)
Number of subjects: 90
Study 20939473 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LMWH)
Number of subjects: 90
Study 18391338 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring simulated maternal-fetal heart rate signals
Number of subjects: 72
Study 16601362 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 10
Study 16601362 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 10
Study 15115965 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2a plus ribavirin (n = 14)
Number of subjects: 32
Study 15115965 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa-2b plus ribavirin (n = 12)
Number of subjects: 32
Study 15115965 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alfa-2a plus placebo (n = 6)
Number of subjects: 32
Study 10754612 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedative and PPIA group
Number of subjects: 103
Study 10754612 — intervention group
Group type: COMPARATOR
Intervention: Sedative group
Number of subjects: 103
Study 8768417 — intervention group
Group type: EXPERIMENTAL
Intervention: Tagging files to remind a doctor to offer a smear during a consultation
Number of subjects: 0
Study 8768417 — intervention group
Group type: EXPERIMENTAL
Intervention: Letters informing of clinic availability and suggesting appointment
Number of subjects: 0
Study 8768417 — intervention group
Group type: EXPERIMENTAL
Intervention: Letters with specific appointments to attend a screening clinic
Number of subjects: 0
Study 8768417 — intervention group
Group type: COMPARATOR
Intervention: Opportunistic screening (Control group)
Number of subjects: 0
Study 1582790 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% O2 + 5% CO2
Number of subjects: 10
Study 1582790 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure oxygen (100% O2)
Number of subjects: 10
Study 1582790 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure oxygen (100% O2) + 5% CO2
Number of subjects: 10
Study 1582790 — intervention group
Group type: COMPARATOR
Intervention: Mild hypoxia (16% O2)
Number of subjects: 10
Study 3908125 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg once daily
Number of subjects: 0
Study 3908125 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg twice daily
Number of subjects: 0
Study 3908125 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg/amiloride 5 mg twice daily (HCT/A)
Number of subjects: 0
Study 31543957 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention to trainee principal investigators
Number of subjects: 20
Study 31543957 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive reinforcement intervention via an email nudge
Number of subjects: 20
Study 31543957 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 31543957 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback regarding the educational programme
Number of subjects: 20
Study 28834178 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential oils mouth rinse
Number of subjects: 60
Study 28834178 — intervention group
Group type: COMPARATOR
Intervention: Dental flossing
Number of subjects: 60
Study 26404425 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray cryotherapy
Number of subjects: 50
Study 26404425 — intervention group
Group type: COMPARATOR
Intervention: Intralesional cryotherapy
Number of subjects: 50
Study 26685904 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating the Blues
Number of subjects: 691
Study 26685904 — intervention group
Group type: EXPERIMENTAL
Intervention: MoodGYM
Number of subjects: 691
Study 26685904 — intervention group
Group type: COMPARATOR
Intervention: Usual GP care
Number of subjects: 691
Study 22658123 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 0.5% solution applied twice daily
Number of subjects: 77
Study 22658123 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution applied twice daily
Number of subjects: 77
Study 20367104 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allograft (ADMA) seeded with autologous gingival fibroblasts
Number of subjects: 10
Study 20367104 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 10
Study 18948799 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted surgery
Number of subjects: 601
Study 18948799 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 601
Study 18948799 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted surgery (converted to open)
Number of subjects: 601
Study 15957830 — intervention group
Group type: EXPERIMENTAL
Intervention: Danshen injection (DSI) 60 ml once a day for 10 days
Number of subjects: 221
Study 15957830 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 221
Study 15957830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 221
Study 11803077 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hepatitis A and B vaccine (Twinrix) administered on days 0, 7, and 21
Number of subjects: 0
Study 11803077 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous administration of monovalent hepatitis A and B vaccines
Number of subjects: 0
Study 11803077 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hepatitis A and B vaccine (Twinrix)
Number of subjects: 0
Study 10429000 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (I‐NO) therapy at doses of 1, 4, and 16 ppm.
Number of subjects: 155
Study 10429000 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nitric oxide (I‐NO) therapy (pooled doses) for treatment failures.
Number of subjects: 155
Study 10429000 — intervention group
Group type: COMPARATOR
Intervention: Placebo group for treatment failures.
Number of subjects: 155
Study 7552524 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolution of critical limb ischaemia
Number of subjects: 82
Study 2082861 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral feedback
Number of subjects: 54
Study 2082861 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback indicating painful electric shock
Number of subjects: 54
Study 2082861 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback indicating subnormal sexual arousal
Number of subjects: 54
Study 347466 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 24
Study 347466 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordiazepam
Number of subjects: 24
Study 347466 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone
Number of subjects: 24
Study 347466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31836942 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst-stage transfer
Number of subjects: 208
Study 31836942 — intervention group
Group type: COMPARATOR
Intervention: Cleavage-stage transfer
Number of subjects: 208
Study 31484531 — intervention group
Group type: EXPERIMENTAL
Intervention: Infertile women
Number of subjects: 720
Study 31484531 — intervention group
Group type: COMPARATOR
Intervention: Fertile women
Number of subjects: 720
Study 28107847 — intervention group
Group type: EXPERIMENTAL
Intervention: Funny videos
Number of subjects: 90
Study 28107847 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfunny videos
Number of subjects: 90
Study 28107847 — intervention group
Group type: COMPARATOR
Intervention: No videos (Control)
Number of subjects: 90
Study 25381629 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg/day)
Number of subjects: 0
Study 25381629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23430007 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video (6-min video about head and neck radiotherapy side effects)
Number of subjects: 38
Study 23430007 — intervention group
Group type: COMPARATOR
Intervention: Verbal information (control group)
Number of subjects: 38
Study 17689633 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypertensive disorders of pregnancy
Number of subjects: 216
Study 15736915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (1.3 g EPA and 0.9 g DHA per day) from week 30 of gestation (FO(pregn/lact))
Number of subjects: 44
Study 15736915 — intervention group
Group type: COMPARATOR
Intervention: Fish oil supplementation (1.3 g EPA and 0.9 g DHA per day) from week 30 of gestation (FO(pregn))
Number of subjects: 44
Study 15736915 — intervention group
Group type: COMPARATOR
Intervention: Control regimen (olive oil or no oil)
Number of subjects: 44
Study 10883412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ, 12.5 mg daily)
Number of subjects: 49
Study 10883412 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril/HCTZ combinations
Number of subjects: 49
Study 9111254 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation of drusen
Number of subjects: 27
Study 9111254 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 27
Study 8472720 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 120 mg t.i.d.
Number of subjects: 1775
Study 8472720 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1775
Study 2436462 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombin method (5,000 units/5 cc. X 2)
Number of subjects: 50
Study 2436462 — intervention group
Group type: COMPARATOR
Intervention: Ligature method
Number of subjects: 50
Study 31419607 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Check‐Up for Expectant Moms (HCEM), a computer‐delivered brief intervention with two booster sessions
Number of subjects: 250
Study 31419607 — intervention group
Group type: COMPARATOR
Intervention: Computer‐delivered control condition
Number of subjects: 250
Study 29062344 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal hospital-based adult triage protocol
Number of subjects: 33
Study 29062344 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department allocation
Number of subjects: 33